Cholecalciferol (vitamin D3): efficacy, safety, and implications in public health
- PMID: 40551736
- PMCID: PMC12183072
- DOI: 10.3389/fnut.2025.1579957
Cholecalciferol (vitamin D3): efficacy, safety, and implications in public health
Abstract
Vitamin D₃ (cholecalciferol) is a fat-soluble secosteroid with essential roles in calcium-phosphorus metabolism, bone health, and an expanding range of extraskeletal processes. Upon synthesis in the skin via ultraviolet B exposure or ingestion from dietary sources, cholecalciferol is hydroxylated in the liver and kidneys to form its active metabolite, calcitriol (1,25-dihydroxyvitamin D), which exerts pleiotropic effects through vitamin D receptor (VDR)-mediated genomic and non-genomic pathways. This narrative review synthesizes evidence on the systemic effects of high-dose cholecalciferol on bone health, metabolism, cardiovascular and immune function, and its emerging roles in neurological, gastrointestinal, reproductive, oncologic, and psychiatric disorders. High-dose vitamin D₃ has demonstrated benefits in specific populations, including improved bone mineral density, immune homeostasis, glycemic control, and reduced inflammation. In patients with chronic kidney disease, cystic fibrosis, and inflammatory bowel disease, targeted supplementation has been associated with clinical improvements. Preclinical models support calcitriol's antiproliferative and neuroprotective functions, and its synergistic effects with chemotherapy, although large-scale randomized controlled trials (RCTs) have yielded mixed or inconclusive results, particularly in cancer, cardiovascular events, and cognitive decline. Methodological variability-such as inconsistent dosing regimens, baseline vitamin D status, and heterogeneous populations-limits definitive conclusions. While vitamin D supplementation is generally safe within recommended limits, excessive intake may cause hypercalcemia or nephrolithiasis, emphasizing the need for personalized strategies. Food fortification and targeted screening remain underutilized yet cost-effective public health interventions. Overall, vitamin D₃ represents a promising but complex therapeutic agent, necessitating further rigorously designed clinical trials to establish evidence-based guidelines for its use in diverse pathological conditions.
Keywords: cholecalciferol; effects on health; high doses; vitamin D; vitamin D3.
Copyright © 2025 Ortiz-Prado, Vasconez-Gonzalez, Izquierdo-Condoy, Suárez-Sangucho, Prieto-Marín, Villarreal-Burbano, Barriga-Collantes, Altamirano-Castillo, Borja-Mendoza, Pazmiño-Almeida and Cadena-Padilla.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Effectiveness and safety of vitamin D in relation to bone health.Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Evid Rep Technol Assess (Full Rep). 2007. PMID: 18088161 Free PMC article.
-
Vitamin D supplementation for sickle cell disease.Cochrane Database Syst Rev. 2017 Jan 20;1(1):CD010858. doi: 10.1002/14651858.CD010858.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 May 28;5:CD010858. doi: 10.1002/14651858.CD010858.pub3. PMID: 28105733 Free PMC article. Updated.
-
Vitamin D supplementation for chronic liver diseases in adults.Cochrane Database Syst Rev. 2017 Nov 3;11(11):CD011564. doi: 10.1002/14651858.CD011564.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2021 Aug 25;8:CD011564. doi: 10.1002/14651858.CD011564.pub3. PMID: 29099543 Free PMC article. Updated.
-
Vitamin D for the management of multiple sclerosis.Cochrane Database Syst Rev. 2018 Sep 24;9(9):CD008422. doi: 10.1002/14651858.CD008422.pub3. Cochrane Database Syst Rev. 2018. PMID: 30246874 Free PMC article.
-
Vitamin D supplementation for chronic liver diseases in adults.Cochrane Database Syst Rev. 2021 Aug 25;8(8):CD011564. doi: 10.1002/14651858.CD011564.pub3. Cochrane Database Syst Rev. 2021. PMID: 34431511 Free PMC article.
References
-
- NIH . NIH. Office of dietary supplements - vitamin D. (2024). Available online at: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/ (Accessed January 5, 2025).
-
- Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D. and Calcium. Ross AC, Taylor CL, Yaktine AL, HBD V. Overview of vitamin D In: Dietary reference intakes for calcium and vitamin D [internet]: National Academies Press (US) (2011) - PubMed
-
- Elsevier Connect . Elsevier. Metabolismo-funciones- toxicidad y estados deficitarios de la vitamina D. (2019). Available online at: https://www.elsevier.com/es-es/connect/metabolismo-funciones-toxicidad-y... (Accessed January 5, 2025).
-
- PubChem . PubChem. Cholecalciferol. (2024). Available online at: https://pubchem.ncbi.nlm.nih.gov/compound/5280795 (Accessed January 5, 2025).
Publication types
LinkOut - more resources
Full Text Sources